May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Intravitreal triamcinolone prolongs the vascular remodelling of choroid after photodynamic therapy.
Author Affiliations & Notes
  • S. Piermarocchi
    Institute of Ophthalmology, University Padova, Padova, Italy
  • E. Pilotto
    Institute of Ophthalmology, University Padova, Padova, Italy
  • S. Vujosevic
    Institute of Ophthalmology, University Padova, Padova, Italy
  • G. Lo Giudice
    Institute of Ophthalmology, University Padova, Padova, Italy
  • M. Sartore
    Institute of Ophthalmology, University Padova, Padova, Italy
  • E. Midena
    Institute of Ophthalmology, University Padova, Padova, Italy
  • Footnotes
    Commercial Relationships  S. Piermarocchi, None; E. Pilotto, None; S. Vujosevic, None; G. Lo Giudice, None; M. Sartore, None; E. Midena, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 3155. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Piermarocchi, E. Pilotto, S. Vujosevic, G. Lo Giudice, M. Sartore, E. Midena; Intravitreal triamcinolone prolongs the vascular remodelling of choroid after photodynamic therapy. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):3155.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To verify if intravitreal triamcinolone (IVT) can modify the course of the vascular events on choroidal circulation which follow photodynamic therapy (PDT). Methods: Eighteen patients (18 eyes) with age–related macular degeneration (AMD) and minimally–classic choroidal newvessels (CNV) received 4 mg of IVT (Group IVT+PDT). After 3 weeks they were treated with PDT. Twenty patients (20 eyes) with AMD–CNV were treated with only PDT according to the standard protocol (Group PDT). Both groups were submitted to fluorescein and indocyanine green angiography before any procedure, 30 min, 1 day, 7 days and 1 month after PDT. Results: Fourteen patients in Group IVT+PDT (78%) and 18 in Group PDT (90%) showed increased permeability either 30 min or 1 day after PDT, of both CNV and normal choroidal vessels within the treatment spot. At 7 days all patients showed different degrees of closure of the CNV and choroidal vessels. At 1 month, 17 patients (94%) in Group IVT+PDT and only 2 (10%) in Group PDT showed angiographic signs of non perfusion of both CNV and normal choroid (P<0.05). Conclusions: Photodynamic therapy (PDT) determines a temporary closure of choroidal vessels and CNV which lasts for some weeks after treatment. Most recurrences are evident at 1 month. In this study IVT seems to prolong the collapsing effect of PDT, both in CNV and normal choroid within the treatment spot. IVT may conceavably block the suspected PDT–mediated pro–angiogenic effect which follows photothrombosis. A randomized trial is needed to verify the long–term efficacy of combining IVT and PDT in the treatment of minimally classic CNV.

Keywords: choroid: neovascularization • photodynamic therapy • age–related macular degeneration 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×